Skip to main content
OpenTrials

Clinical trial condition

Glaucoma, Open-Angle

Explore clinical trials studying Glaucoma, Open-Angle. Study availability and eligibility vary by location and protocol.

701 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Glaucoma, Open-Angle trial results

Completed

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

NCT00277498

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Flagstaff, Arizona, United States
  • Pfizer Investigational Site Artesia, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View all 64 locations
View Trial Details
Completed

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

NCT00140049

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open Angle, +2 more
Locations
  • Pfizer Investigational Site Caen, France
  • Pfizer Investigational Site Clermont-Ferrand, France
  • Pfizer Investigational Site Lyon, France
  • Pfizer Investigational Site Marseille, France
View all 25 locations
View Trial Details
Completed

Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension

NCT00219596

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open Angle, +2 more
Locations
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Guangzhou, Guangdong, China
  • Pfizer Investigational Site Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

NCT00801437

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +1 more
Locations
  • Pfizer Investigational Site Banovce N. Bebravou, Slovakia
  • Pfizer Investigational Site Banská Bystrica, Slovakia
  • Pfizer Investigational Site Bojnice, Slovakia
  • Pfizer Investigational Site Bratislava, Slovakia
View all 39 locations
View Trial Details
Completed

STARflo European Safety and Efficacy Study

NCT02272569

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
Locations
  • UZA Edegem, Belgium
  • CHU Sart Tilman Liège, Belgium
  • MHAT Central Onco Hospital Plovdiv, Bulgaria
  • Hopital de la Croix-Rousse Lyon, France
View Trial Details
Completed

A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

NCT00647101

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +1 more
Locations
  • Pfizer Investigational Site Albi, France
  • Pfizer Investigational Site Ambert, France
  • Pfizer Investigational Site Amboise, France
  • Pfizer Investigational Site Angers, France
View all 176 locations
View Trial Details

Related conditions